Cochrane Abstracts
Angioplasty versus bare metal stenting for superficial femoral artery lesions
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Angioplasty Versus Bare Metal Stenting for Superficial Femoral Artery Lesions." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434369/all/Angioplasty_versus_bare_metal_stenting_for_superficial_femoral_artery_lesions.
Angioplasty versus bare metal stenting for superficial femoral artery lesions. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434369/all/Angioplasty_versus_bare_metal_stenting_for_superficial_femoral_artery_lesions. Accessed January 14, 2025.
Angioplasty versus bare metal stenting for superficial femoral artery lesions. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434369/all/Angioplasty_versus_bare_metal_stenting_for_superficial_femoral_artery_lesions
Angioplasty Versus Bare Metal Stenting for Superficial Femoral Artery Lesions [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434369/all/Angioplasty_versus_bare_metal_stenting_for_superficial_femoral_artery_lesions.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Angioplasty versus bare metal stenting for superficial femoral artery lesions
ID - 434369
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434369/all/Angioplasty_versus_bare_metal_stenting_for_superficial_femoral_artery_lesions
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
